Join us Tuesday, March 5, at the Psychedelic Assembly, 222 East 46th St, 7-9 PM, for a panel discussion on the current and future state of the psychedelic therapy ecosystem. In finding safer paths to inner space, what are the best practices and ethical considerations in ketamine therapy? Whether you or a loved one is exploring an in-person experience or with a telehealth provider, where do you go to try legal psychedelic treatment in New York City, and what do you look for to know what is right for you?
As MDMA becomes available as soon as August of 2024, what will the future rollout look like and mean for people who want to experience this therapy? How will the delivery of ketamine pave the way for future infrastructure and impact when it comes to ensuring safe, effective outcomes?
This engaging discussion will feature Steven Radowitz, MD of Nushama, Casey Paleos, MD of Nautilus Sanctuary & Fluence, and Ross Ellenhorn, LICSW, PhD of Cardea, and Marissa Feinberg, Triple Bottom Why & Nushama, serving as the moderator.
If you plan to be present and would like to nominate questions for the panel, please email me with your suggestions. There will also be a Q&A for any topics you’re curious about that we don’t cover.